A computational model of CAR T-cell immunotherapy predicts leukemia patient responses at remission, resistance, and relapse

Lunan Liu, Chao Ma, Zhuoyu Zhang, Weqiang Chen
doi: https://doi.org/10.1101/2021.09.21.21263913

Article Information

doi 
https://doi.org/10.1101/2021.09.21.21263913
History 
  • September 23, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Lunan Liu1,#,
  2. Chao Ma1,2,#,
  3. Zhuoyu Zhang1 and
  4. Weqiang Chen1,2,3,4,*
  1. 1Department of Mechanical and Aerospace Engineering, New York University, Brooklyn, NY 11201, USA
  2. 2Department of Biomedical Engineering, New York University, Brooklyn, NY 11201, USA
  3. 3Perlmutter Cancer Center, NYU Langone Health, New York, NY 10016, USA
  4. 4Department of Pathology, NYU Langone Health, New York, NY 10016, USA
  1. ↵*Correspondence should be addressed to W. Chen (email: wchen{at}nyu.edu)

  1. ↵# These authors contribute equally.

Back to top
Posted September 23, 2021.
Download PDF
Data/Code
Email
A computational model of CAR T-cell immunotherapy predicts leukemia patient responses at remission, resistance, and relapse
Lunan Liu, Chao Ma, Zhuoyu Zhang, Weqiang Chen
medRxiv 2021.09.21.21263913; doi: https://doi.org/10.1101/2021.09.21.21263913
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area